Moreover, serotonin, a CNS neurotransmitter, favors the expansion in vitro of Treg cells from MS patients while reducing production of IL-17 by Tconv cells, suggesting that it acts as a neuroprotectant in the attempt of resolving inflammation (190). Here, IL17A is linked to myeloid sarcoma.